The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images.

OpenAI announced this week its AI research assistant, which it calls “ deep research .” Powered by OpenAI’s o3-mini model ...

One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ...

Breast cancer is the most common cancer among women in the UK, with one in seven women being diagnosed with breast cancer in ...

Artificial intelligence systems require consistent monitoring and staffing to put in place and to keep them working well.

Cancer detection rates were 6·4 per 1,000 screened in the group that underwent mammography with AI use compared to five per 1 ...

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The ...